Scholtz & Company’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,980
| Closed | -$222K | – | 64 |
|
|
2021
Q3 | $222K | Sell |
1,980
-805
| -29% | -$90.3K | 0.08% | 64 |
|
|
2021
Q2 | $451K | Sell |
2,785
-67
| -2% | -$10.9K | 0.15% | 58 |
|
|
2021
Q1 | $348K | Sell |
2,852
-77
| -3% | -$9.4K | 0.13% | 59 |
|
|
2020
Q4 | $448K | Buy |
2,929
+364
| +14% | +$55.7K | 0.18% | 58 |
|
|
2020
Q3 | $215K | Buy |
+2,565
| New | +$215K | 0.09% | 65 |
|